Peyronie's Disease: Overview and Recent Treatment Advances

Peyronie's Disease: Overview and Recent Treatment Advances


Identification: unj_ja15_01
Issue: July-August 2015
Volume: Volume 35 Number 4
Credits (Post Test and/or Evaluation Required)
Available until 08/31/2017
  • 1.40 - CH
  • 0.00 - Rx
  • 0.00 - CME


Description

Contact hours available until 8/31/17.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation.

Faculty, Planners and Authors Conflict of Interest Disclosure:
The author, editor, and education director reported no actual or potential conflict of interest in relation to this continuing nursing education article.

Urologic Nursing Editorial Board Statements of Disclosure
Christine Bradway, PhD, CRNP, FAAN, disclosed that she is a Consultant for Direct Supply, Inc. All other Editorial Board members, as well as the Editor, author, and Education Director, reported no actual or potential conflict of interest in relation to this continuing nursing education article.

Commercial Support and Sponsorship:
No commercial support or sponsorship declared.

Accreditation Statement:
Society of Urologic Nurses and Associates is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center''s Commission on Accreditation.

SUNA is a provider approved by the California Board of Registered Nursing, provider number, CEP 5556.

The purpose of this CNE activity is to provide an overview of Peyronie's disease, along with evaluation and advances in treatment therapies. For those wishing to obtain CNE credit, an evaluation follows. After studying the information presented in this article, the nurse will be able to:

  1. Define Peyronie's disease.
  2. Discuss the procedure to evaluate for Peyronie's disease.
  3. Describe current treatment therapies for Peyronie's disease.
  4. Explain advances in treatment therapies for Peyronie's disease.

Credits Available


Expired On: Aug 31, 2017

You must be logged in and own this product in order to post comments.